Day: July 13, 2022

RenovoRx Launches “The RenovoRx Story” Video Series Spotlighting the RenovoRx Journey, its Leadership and Innovative Treatment Platform Targeting Difficult-to-Treat Cancers

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced the launch of a new video series – The RenovoRx Story. This video series provides viewers with a unique opportunity to learn more about the Company, its leadership team, and the innovative RenovoTAMP™ (RenovoRx Trans-Arterial Micro-Perfusion) therapeutic platform. Also highlighted in the video series is the Company’s multi-center TIGeR-PaC Phase 3 clinical trial in locally advanced pancreatic cancer.